Fanlin Meng,Zahraa Al-Khafaji,Khursheed Muzammil et al.
Fanlin Meng et al.
Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) represents a high-risk subtype of AML, characterized by poor prognosis and limited therapeutic options. Recent updates in the WHO and ICC classifications have redefined AM...
Why JAK2-mutated neutrophils deserve to be on center stage in polycythemia vera [0.03%]
为何Janus激酶2(JAK2)突变的中性粒细胞在真性红细胞增多症中应成为研究重点
Lucia Masarova,Albert Qin,Chang Ho Yoon et al.
Lucia Masarova et al.
Avoidance of related donors in CAEBV with germline immune variants: long-termoutcome of matched unrelated donor HSCT - a case report [0.03%]
携带免疫基因 germline变异的CAEBV患者进行匹配无关供者造血干细胞移植的长期疗效分析：1例报告
Xinran Wang,Jia Gu,Ning An et al.
Xinran Wang et al.
This study reports an adult-onset case of NK cell-predominant chronic active Epstein-Barr virus infection (CAEBV) harboring multiple heterozygous germline variants affecting antiviral immunity. Functional assessments of NK cell cytotoxicity...
Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia [0.03%]
用于费城染色体阳性慢性粒细胞白血病急变期T315I突变型PML-RARA阳性患者的艾斯明加与脉冲式ATRA作为缓解后治疗的研究
Roberta Mazzarella,Laura Cicconi,Salvatore Perrone et al.
Roberta Mazzarella et al.
Promyelocytic blast crisis (BC) of CML is an extremely rare event, with only seven cases described as arising during therapy with TKIs. We present a 68-year-old male who developed promyelocytic blast crisis 12 months after CML diagnosis and...
Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms [0.03%]
流式细胞仪特异性panel在浆细胞样树突状细胞肿瘤性疾病鉴别诊断中的应用价值研究
Florian Renosi,Sabeha Biichlé,Xavier Roussel et al.
Florian Renosi et al.
Re-treatment of relapse in elderly AML with time-limited venetoclax-based regimen: a case report and literature review [0.03%]
关于老年AML复发再诱导治疗的病例报告和文献回顾（基于有限疗程的Venetoclax方案）
Jun Yen Ng,Veena Gullapalli,Jad Othman et al.
Jun Yen Ng et al.
Venetoclax and hypomethylating agent combination therapy is now the standard of care in acute myeloid leukemia (AML) for patients ineligible for intensive therapy, including the elderly; however, venetoclax and low-dose cytarabine remain a ...
Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia [0.03%]
FM80TBI预处理方案用于急性髓系白血病初始胎盘脐带血移植的疗效分析
Masahiro Akimoto,Takayoshi Tachibana,Masatsugu Tanaka et al.
Masahiro Akimoto et al.
Outcomes of allogeneic stem cell transplantation in older patients with acute myeloid leukemia (AML) have been unsatisfactory. At our center, cord blood transplantation (CBT) using FM80TBI has been implemented in older patients or those wit...
Superior response and survival of intensive chemotherapy over venetoclax plus azacitidine in newly diagnosed KIT-mutated acute myeloid leukemia [0.03%]
新诊断的KIT突变急性髓系白血病患者接受强化化疗疗效优于维奈克拉联合地西他滨
Qingli Ji,Xinwen Jiang,Xiaoqing Li et al.
Qingli Ji et al.
Although KIT mutations hold significant prognostic value in acute myeloid leukemia (AML), their impact on selecting first-line treatment remains unclear. This retrospective study of 222 newly diagnosed AML patients therefore compared the ef...
Synergistic adverse prognostic impact of CD30 and Epstein-Barr virus in peripheral T-cell lymphoma: CD30 identifies a high-risk subgroup in Epstein-Barr virus-encoded RNA -positive patients [0.03%]
CD30和EB病毒在周围T细胞淋巴瘤中的协同不良预后影响：CD30在EB病毒编码RNA阳性患者中识别高危亚组
Ze-Tao Chen,Ling Huang,Xiao-Dan Zhang et al.
Ze-Tao Chen et al.
Patients with Epstein–Barr virus–encoded RNA (EBER)-positive Peripheral T-cell lymphoma (PTCL) exhibit poor survival. Current prognostic scores lack efficacy in this group, necessitating more specific biological markers. This multicenter ...
Prognostic significance of Ki-67 in grade 3A follicular lymphoma and development of a novel PFS nomogram [0.03%]
Ki-67在三级A Follicular Lymphoma中的预后意义及新型PFS预测模型的建立
Xinyue Li,Qi Zhao,Ling Li et al.
Xinyue Li et al.
Background: Follicular lymphoma (FL) is an indolent yet highly heterogeneous B-cell lymphoproliferative disorder. The introduction of CD20 monoclonal antibodies has significantly improved patient survival; however, the op...